SERUM PEPSINOGEN I AND PEPSINOGEN II AS NON-INVASIVE BIOMARKERS FOR THE DIAGNOSIS OF CHRONIC ATROPHIC GASTRITIS
Atrophic gastritis, intestinal metaplasia and dysplasia of the gastric mucosa are major risk factors for the development of an intestinal type of gastric cancer. The selection of patients with such lesions could help with early detection and improve better the prognosis. Esophagogastroscopy is the &...
Saved in:
Main Authors: | Zornica Gorcheva (Author), Valeriya Racheva (Author), Mirela Vasileva (Author) |
---|---|
Format: | Book |
Published: |
Peytchinski Publishing,
2022-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Serum miR-101-3p combined with pepsinogen contributes to the early diagnosis of gastric cancer
by: Weiwei Zeng, et al.
Published: (2020) -
Detection of pepsinogen and Helicobacter pylori in preschool age children with secretory otitis media
by: Wael F Ismaeil, et al.
Published: (2018) -
Correlation between the Serum Pepsinogen I Level and the Symptom Degree in Proton Pump Inhibitor-Users Administered with a Probiotic
by: Muneki Igarashi, et al.
Published: (2014) -
Histopathologic Diagnosis of Atrophic Gastritis and Intestinal Metaplasia
by: Do Youn Park
Published: (2020) -
Endoscopic Diagnosis and Classification of Atrophic Gastritis and Intestinal Metaplasia
by: Seong Woo Jeon
Published: (2020)